Dosage modifications are recommended for patients with hepatic impairment and those on concomitant moderate CYP3A inhibitors. The use of Journavx for moderate to severe pain has not been studied ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

A massive stride has been made in the pain medication industry. The U.S. Food and Drug Administration (FDA) announced Thursday its approval of a non-opioid treatment for moderate to severe acute pain ...

Lunesta’s (eszopiclone) dosage for insomnia is typically 1 milligram (mg) once per day. Your dosing schedule may vary based on factors that include your symptoms and other medications you may be ...

Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally represents a ...

The usual Xadago (safinamide) dosage for Parkinson’s disease is one 50-mg or 100-mg oral tablet taken once daily. Specific dosages may vary depending on various factors. Always take the Xadago ...

The dosage can vary depending on the type of migraine ... If you have trouble swallowing tablets, see this article for tips on how to take this form of medication. You can also talk with your ...

The dosage for bupropion varies depending on the condition it’s being used to treat and the form of the drug you’re prescribed. Your doctor will prescribe the dosage and form that’s best for ...

A Phase II dose-escalation study of sorafenib was conducted in 44 evaluable patients, 19 of whom received prior therapy. [82] The initial dosage was 400 mg twice daily for 28 days, followed by 600 ...

The International Council for Harmonisation (ICH)'s guideline entitled, ICH M13A: Bioequivalence for Immediate Release Solid Oral Dosage Forms is intended to provide recommendations on conducting ...